IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT05516797

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05516797
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05516797. Randomized; no masking; primary purpose treatment. Start 2022-09-22 (actual); primary completion 2024-03-01 (actual). Results posted on 2025-03-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
Acronym
IGNITE
Intervention (Device)
Continuous Glucose Monitoring (CGM)
Lead sponsor
HealthPartners Institute (class: other)
Collaborator
Virta Health (class: industry)
Collaborator
Abbott Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct05516797
Content hash
4db7839a03916cd1460ab4c9ffc65522fad390332bb46c17b44042c4f1b81c4c